AbbVie’s Skyrizi took home the top spot for most pharma brand ad impressions in April, according to data released by iSpot.tv on Wednesday afternoon. The psoriasis treatment garnered an impressions ...

For the fourth year running—and the third in a row for Skyrizi specifically—an AbbVie immunology med has claimed the top spot in the full-year TV drug ad spending rankings, as calculated by iSpot.TV.

The season of Skyrizi continues as the treatment for psoriasis, Crohn’s disease and psoriatic arthritis from AbbVie notched the latest quarterly crown for over-the-counter (OTC) pharma and Rx brands.